Arbutus Biopharma Ownership 2024 | Who Owns Arbutus Biopharma Now?
Institutional Ownership
24.32%
Insider Ownership
22.30%
Retail Ownership
53.38%
Institutional Holders
93.00
Arbutus Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 11.93% | 0.01% | 20,960,268 | 12,129,971 | 137.37% | 64,767,230 | Jun 30, 2024 |
| WHITEFORT CAPITAL MANAGEMENT, LP | 7.33% | 24.51% | 12,867,967 | 5,815 | 0.05% | 39,762,018 | Jun 30, 2024 |
| BLACKROCK INC. | 6.58% | 0.00% | 11,552,066 | 1,147,447 | 11.03% | 35,695,884 | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | 4.88% | 4.30% | 8,571,751 | 729,824 | 9.31% | 26,486,711 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.00% | 0.00% | 7,022,095 | 1,034,188 | 17.27% | 21,698,274 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.89% | 0.00% | 3,313,158 | 354,271 | 11.97% | 10,240,293 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.87% | 1.92% | 3,289,260 | 1,215,077 | 58.58% | 10,163,813 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.71% | 0.02% | 3,000,000 | - | - | 9,270,000 | Jun 30, 2024 |
| FOURWORLD CAPITAL MANAGEMENT LLC | 1.69% | 5.50% | 2,972,527 | -28,000 | -0.93% | 9,185,108 | Jun 30, 2024 |
| STATE STREET CORP | 1.67% | 0.00% | 2,934,481 | 322,591 | 12.35% | 9,067,546,000 | Jun 30, 2024 |
| BLACKBARN CAPITAL PARTNERS LP | 1.18% | 0.57% | 2,070,900 | - | - | 6,399,081 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.96% | 0.02% | 1,685,000 | -1,835,382 | -52.14% | 5,206,650 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 0.96% | 0.14% | 1,681,090 | 1,681,090 | 100.00% | 5,194,568 | Jun 30, 2024 |
| FOURWORLD CAPITAL MANAGEMENT LLC | 0.89% | 2.91% | 1,570,000 | - | - | 4,851,300 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.82% | 0.01% | 1,445,000 | - | - | 4,465,050 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.78% | 0.01% | 1,369,839 | 2,300 | 0.17% | 4,232,802 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.60% | 0.00% | 1,051,325 | -5,279 | -0.50% | 3,248,594,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.53% | 0.03% | 926,534 | -3,144,125 | -77.24% | 2,862,990 | Jun 30, 2024 |
| CORBIN CAPITAL PARTNERS, L.P. | 0.49% | 4.25% | 853,304 | - | - | 2,201,524 | Jun 30, 2024 |
| SABA CAPITAL MANAGEMENT, L.P. | 0.37% | 0.03% | 651,427 | 277,967 | 74.43% | 2,012,909 | Jun 30, 2024 |
Arbutus Biopharma's largest institutional shareholder is MORGAN STANLEY, holding 11.93% of the company's total share outstanding, currently valued at $64.77M. The top 10 institutional shareholders own together 43.55% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WHITEFORT CAPITAL MANAGEMENT, LP | 7.33% | 24.51% | 12,867,967 | 5,815 | 0.05% | 39,762,018 | Jun 30, 2024 |
| FOURWORLD CAPITAL MANAGEMENT LLC | 1.69% | 5.50% | 2,972,527 | -28,000 | -0.93% | 9,185,108 | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | 4.88% | 4.30% | 8,571,751 | 729,824 | 9.31% | 26,486,711 | Jun 30, 2024 |
| CORBIN CAPITAL PARTNERS, L.P. | 0.49% | 4.25% | 853,304 | - | - | 2,201,524 | Jun 30, 2024 |
| FOURWORLD CAPITAL MANAGEMENT LLC | 0.89% | 2.91% | 1,570,000 | - | - | 4,851,300 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.87% | 1.92% | 3,289,260 | 1,215,077 | 58.58% | 10,163,813 | Jun 30, 2024 |
| BLACKBARN CAPITAL PARTNERS LP | 1.18% | 0.57% | 2,070,900 | - | - | 6,399,081 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 0.96% | 0.14% | 1,681,090 | 1,681,090 | 100.00% | 5,194,568 | Jun 30, 2024 |
| FREESTONE CAPITAL HOLDINGS, LLC | 0.31% | 0.06% | 546,252 | 546,252 | 100.00% | 1,687,919 | Jun 30, 2024 |
| QUINN OPPORTUNITY PARTNERS LLC | 0.09% | 0.06% | 165,132 | 165,132 | 100.00% | 510,258 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.35% | 0.04% | 612,277 | - | - | 1,891,936 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.04% | 28,647 | 28,647 | 100.00% | 88,519 | Jun 30, 2024 |
| KADES & CHEIFETZ LLC | 0.01% | 0.04% | 20,000 | - | - | 61,800 | Jun 30, 2024 |
| SABA CAPITAL MANAGEMENT, L.P. | 0.37% | 0.03% | 651,427 | 277,967 | 74.43% | 2,012,909 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.26% | 0.03% | 457,578 | 21,072 | 4.83% | 1,413,916 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.53% | 0.03% | 926,534 | -3,144,125 | -77.24% | 2,862,990 | Jun 30, 2024 |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 0.06% | 0.03% | 100,761 | -15,500 | -13.33% | 311,351 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.96% | 0.02% | 1,685,000 | -1,835,382 | -52.14% | 5,206,650 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.02% | 41,614 | 41,614 | 100.00% | 128,587 | Jun 30, 2024 |
| WMG FINANCIAL ADVISORS, LLC | 0.01% | 0.02% | 12,605 | - | - | 38,949 | Jun 30, 2024 |
The largest Arbutus Biopharma shareholder by % of total assets is WHITEFORT CAPITAL MANAGEMENT, LP. The company owns 12.87M shares of Arbutus Biopharma (ABUS), representing 24.51% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 11.93% | 0.01% | 20,960,268 | 12,129,971 | 137.37% | 64,767,230 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 0.96% | 0.14% | 1,681,090 | 1,681,090 | 100.00% | 5,194,568 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.87% | 1.92% | 3,289,260 | 1,215,077 | 58.58% | 10,163,813 | Jun 30, 2024 |
| BLACKROCK INC. | 6.58% | 0.00% | 11,552,066 | 1,147,447 | 11.03% | 35,695,884 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.00% | 0.00% | 7,022,095 | 1,034,188 | 17.27% | 21,698,274 | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | 4.88% | 4.30% | 8,571,751 | 729,824 | 9.31% | 26,486,711 | Jun 30, 2024 |
| FREESTONE CAPITAL HOLDINGS, LLC | 0.31% | 0.06% | 546,252 | 546,252 | 100.00% | 1,687,919 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.89% | 0.00% | 3,313,158 | 354,271 | 11.97% | 10,240,293 | Jun 30, 2024 |
| STATE STREET CORP | 1.67% | 0.00% | 2,934,481 | 322,591 | 12.35% | 9,067,546,000 | Jun 30, 2024 |
| SABA CAPITAL MANAGEMENT, L.P. | 0.37% | 0.03% | 651,427 | 277,967 | 74.43% | 2,012,909 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.15% | 0.01% | 255,401 | 195,401 | 325.67% | 789,189 | Jun 30, 2024 |
| QUINN OPPORTUNITY PARTNERS LLC | 0.09% | 0.06% | 165,132 | 165,132 | 100.00% | 510,258 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.12% | 0.01% | 208,152 | 105,228 | 102.24% | 643,190 | Jun 30, 2024 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 0.05% | 0.00% | 89,695 | 89,695 | 100.00% | 277,158 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.28% | 0.00% | 493,729 | 86,104 | 21.12% | 1,525,622 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 75,039 | 75,039 | 100.00% | 231,871 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 65,080 | 65,080 | 100.00% | 201,097 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.02% | 41,614 | 41,614 | 100.00% | 128,587 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.08% | 0.00% | 137,620 | 41,580 | 43.29% | 425,246 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.22% | 0.00% | 380,583 | 41,368 | 12.20% | 1,176,001 | Jun 30, 2024 |
As of Jun 30 2024, Arbutus Biopharma's largest institutional buyer is MORGAN STANLEY. The company purchased 12.13M stocks of ABUS, valued at $64.77M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | 0.53% | 0.03% | 926,534 | -3,144,125 | -77.24% | 2,862,990 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.96% | 0.02% | 1,685,000 | -1,835,382 | -52.14% | 5,206,650 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.03% | 0.00% | 52,800 | -1,300,080 | -96.10% | 163,152 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -187,400 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.01% | - | 18,486 | -107,728 | -85.35% | 57,122 | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -99,055 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.01% | 0.00% | 14,886 | -83,030 | -84.80% | 45,998 | Jun 30, 2024 |
| UBS GROUP AG | 0.03% | - | 55,665 | -79,158 | -58.71% | 172,005 | Jun 30, 2024 |
| FMR LLC | 0.06% | - | 100,818 | -65,024 | -39.21% | 311,527 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -62,439 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -50,110 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | - | 48,034 | -41,152 | -46.14% | 148,000 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.01% | 0.00% | 26,191 | -39,776 | -60.30% | 80,930,000 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -35,000 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.12% | 0.00% | 208,969 | -33,243 | -13.72% | 645,714 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 0.01% | 0.00% | 20,000 | -30,000 | -60.00% | 61,800 | Jun 30, 2024 |
| FOURWORLD CAPITAL MANAGEMENT LLC | 1.69% | 5.50% | 2,972,527 | -28,000 | -0.93% | 9,185,108 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -19,644 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.09% | 0.00% | 157,329 | -17,376 | -9.95% | 486,147 | Jun 30, 2024 |
As of Jun 30 2024, Arbutus Biopharma's biggest institutional seller is WOODLINE PARTNERS LP. The company sold -3.14M shares of ABUS, valued at $2.86M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 0.96% | 0.14% | 1,681,090 | 1,681,090 | 100.00% | 5,194,568 | Jun 30, 2024 |
| FREESTONE CAPITAL HOLDINGS, LLC | 0.31% | 0.06% | 546,252 | 546,252 | 100.00% | 1,687,919 | Jun 30, 2024 |
| QUINN OPPORTUNITY PARTNERS LLC | 0.09% | 0.06% | 165,132 | 165,132 | 100.00% | 510,258 | Jun 30, 2024 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 0.05% | 0.00% | 89,695 | 89,695 | 100.00% | 277,158 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 75,039 | 75,039 | 100.00% | 231,871 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 65,080 | 65,080 | 100.00% | 201,097 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.02% | 41,614 | 41,614 | 100.00% | 128,587 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.04% | 28,647 | 28,647 | 100.00% | 88,519 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 23,927 | 23,927 | 100.00% | 73,934 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.01% | 0.00% | 17,038 | 17,038 | 100.00% | 52,647 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.01% | 0.02% | 11,000 | 11,000 | 100.00% | 33,990 | Jun 30, 2024 |
| COVESTOR LTD | 0.00% | 0.01% | 6,700 | 6,700 | 100.00% | 21,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 5,634 | 5,634 | 100.00% | 17,465 | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | 0.00% | 0.01% | 3,800 | 3,800 | 100.00% | 11,000 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 1,206 | 1,206 | 100.00% | 3,727 | Jun 30, 2024 |
| HARTFORD FINANCIAL MANAGEMENT INC. | 0.00% | 0.00% | 900 | 900 | 100.00% | 2,781 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 830 | 830 | 100.00% | 2,565 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 742 | 742 | 100.00% | 2,300 | Jun 30, 2024 |
| CENTRAL TRUST CO | 0.00% | - | 100 | 100 | 100.00% | 309 | Jun 30, 2024 |
| OPAL WEALTH ADVISORS, LLC | 0.00% | 0.00% | 100 | 100 | 100.00% | 309 | Jun 30, 2024 |
| PICTON MAHONEY ASSET MANAGEMENT | - | - | 79 | 79 | 100.00% | 1,000 | Jun 30, 2024 |
Arbutus Biopharma's largest new institutional shareholder by number of shares is RUBRIC CAPITAL MANAGEMENT LP, purchased 1.68M shares, valued at $5.19M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CENTIVA CAPITAL, LP | - | - | - | -187,400 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -99,055 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -62,439 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -50,110 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -35,000 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -19,644 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -13,268 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -11,033 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -10,482 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,340 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL SYNERGIES WEALTH ADVISORS, INC. | - | - | - | -3,600 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -24 | -100.00% | - | Jun 30, 2024 |
Arbutus Biopharma's largest sold out institutional shareholder by shares sold is CENTIVA CAPITAL, LP, sold -0.19M shares, valued at -, as of undefined.
Arbutus Biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Jacob Funds Inc. | 0.75% | 171,400 | - | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.21% | 107,845 | - | - | Mar 31, 2024 |
| Morgan Stanley Insight Fund | 0.15% | 2,360,400 | 1,006,916 | 74.39% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.05% | 25,796 | - | - | Apr 30, 2021 |
| PRIMECAP Odyssey Funds | 0.04% | 328,100 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 236,161 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 19,583 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.03% | 40,040 | - | - | Jan 31, 2024 |
| AMG FUNDS III | 0.03% | 140,368 | - | - | Mar 28, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 66,847 | - | - | Feb 29, 2024 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.02% | 1,160,535 | 151,923 | 15.06% | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.02% | 105,053 | - | - | Aug 31, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 5,024,488 | -1,675,341 | -25.01% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,291 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.01% | 107,861 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 349,358 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 82,264 | 661 | 0.81% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,279,009 | 49,171 | 4.00% | Feb 29, 2024 |
| ETF Managers Trust | 0.01% | 42,518 | -5,640 | -11.71% | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 76,665 | -888 | -1.15% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 16,484 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 9,124 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 15,861 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 88,397 | -6,087 | -6.44% | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 72,246 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 25,400 | -3,906 | -13.33% | Mar 31, 2024 |
| Amplify ETF Trust | 0.00% | 43,155 | 43,155 | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 44,905 | -11,388 | -20.23% | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 65,896 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 5,589 | -1,367 | -19.65% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 106,567 | 65,490 | 159.43% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 41,800 | -400 | -0.95% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,513 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 668,418 | 5,164 | 0.78% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 41,700 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 59,432 | -3,784 | -5.99% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,934 | 928 | 13.25% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 5,807,184 | -105,629 | -1.79% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 573,910 | 76,327 | 15.34% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,139 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 39,864 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 48,621 | 527 | 1.10% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 4,800 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 565 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 17,413 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 31,091 | 4,275 | 15.94% | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 2,875 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 11,469 | -107 | -0.92% | Jan 31, 2024 |
| ProFunds | 0.00% | 983 | -83 | -7.79% | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 490 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 232,845 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 20,630 | 1,150 | 5.90% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 74 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 13,810 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 5,603 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 55,373 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,659 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 41,612 | 2,891 | 7.47% | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 103,000 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 14,354 | 156 | 1.10% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 2,271 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 84,100 | - | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 53,132 | 965 | 1.85% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 471 | - | - | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 100 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 76,649 | 6,706 | 9.59% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,000 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 50,453 | 8,329 | 19.77% | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 36,600 | - | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 32,635 | 2,054 | 6.72% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 7,020 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS TRUST | 0.00% | 21,562 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 14,072 | - | - | Dec 31, 2023 |
| Legg Mason Global Asset Management Trust | 0.00% | 30,064 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 16,101 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 17,817 | 3,578 | 25.13% | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 17,286 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 200 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 16,700 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 9,539 | - | - | Feb 29, 2024 |
Arbutus Biopharma's largest mutual fund holder by % of total assets is "Jacob Funds Inc.", owning 171.40K shares, compromising 0.75% of its total assets.
Arbutus Biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 93 | -27.34% |
| 31 Mar, 24 | 128 | 5.79% |
| 31 Dec, 23 | 121 | 15.24% |
| 30 Sep, 23 | 105 | -10.26% |
| 30 Jun, 23 | 117 | -10.00% |
| 31 Mar, 23 | 130 | 8.33% |
| 31 Dec, 22 | 120 | -9.77% |
| 30 Sep, 22 | 133 | 12.71% |
| 30 Jun, 22 | 118 | -5.60% |
| 31 Mar, 22 | 125 | -8.76% |
| 31 Dec, 21 | 137 | 18.10% |
| 30 Sep, 21 | 116 | 20.83% |
| 30 Jun, 21 | 96 | -4.95% |
| 31 Mar, 21 | 101 | 16.09% |
| 31 Dec, 20 | 87 | 17.57% |
| 30 Sep, 20 | 74 | 51.02% |
| 30 Jun, 20 | 49 | 4.26% |
| 31 Mar, 20 | 47 | -14.55% |
| 31 Dec, 19 | 55 | 25.00% |
| 30 Sep, 19 | 44 | -24.14% |
| 30 Jun, 19 | 58 | -18.31% |
| 31 Mar, 19 | 71 | -5.33% |
| 31 Dec, 18 | 75 | -18.48% |
| 30 Sep, 18 | 92 | 24.32% |
| 30 Jun, 18 | 74 | 42.31% |
| 31 Mar, 18 | 52 | 1.96% |
| 31 Dec, 17 | 51 | -3.77% |
| 30 Sep, 17 | 53 | 10.42% |
| 30 Jun, 17 | 48 | -12.73% |
| 31 Mar, 17 | 55 | -6.78% |
| 31 Dec, 16 | 59 | 11.32% |
| 30 Sep, 16 | 53 | -1.85% |
| 30 Jun, 16 | 54 | 1.89% |
| 31 Mar, 16 | 53 | - |
| 31 Dec, 15 | 53 | -5.36% |
| 30 Sep, 15 | 56 | 5500.00% |
| 30 Jun, 15 | 1 | - |
As of 30 Jun 24, 93 institutions are holding Arbutus Biopharma's shares, representing a decrease of -27.34% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 42,710,818 | -48.57% |
| 31 Mar, 24 | 83,042,471 | 5.67% |
| 31 Dec, 23 | 78,585,833 | 11.02% |
| 30 Sep, 23 | 70,787,020 | 6.95% |
| 30 Jun, 23 | 66,185,386 | 6.00% |
| 31 Mar, 23 | 62,438,184 | 15.29% |
| 31 Dec, 22 | 54,155,892 | 16.36% |
| 30 Sep, 22 | 46,543,439 | 5.15% |
| 30 Jun, 22 | 44,265,785 | 0.91% |
| 31 Mar, 22 | 43,865,375 | 10.55% |
| 31 Dec, 21 | 39,680,290 | 13.74% |
| 30 Sep, 21 | 34,886,241 | 20.74% |
| 30 Jun, 21 | 28,892,880 | 11.28% |
| 31 Mar, 21 | 25,963,904 | 16.64% |
| 31 Dec, 20 | 22,260,347 | -7.80% |
| 30 Sep, 20 | 24,143,336 | -7.57% |
| 30 Jun, 20 | 26,122,035 | -0.62% |
| 31 Mar, 20 | 26,283,816 | 8.33% |
| 31 Dec, 19 | 24,262,246 | 24.65% |
| 30 Sep, 19 | 19,463,851 | -7.81% |
| 30 Jun, 19 | 21,113,654 | -12.43% |
| 31 Mar, 19 | 24,109,692 | -0.27% |
| 31 Dec, 18 | 24,175,304 | 0.67% |
| 30 Sep, 18 | 24,014,986 | 8.13% |
| 30 Jun, 18 | 22,208,597 | 20.85% |
| 31 Mar, 18 | 18,377,136 | -46.28% |
| 31 Dec, 17 | 34,210,466 | 3.62% |
| 30 Sep, 17 | 33,015,033 | -10.50% |
| 30 Jun, 17 | 36,888,158 | 1.56% |
| 31 Mar, 17 | 36,323,022 | 0.36% |
| 31 Dec, 16 | 36,191,006 | 8.56% |
| 30 Sep, 16 | 33,336,170 | 89.93% |
| 30 Jun, 16 | 17,551,752 | -0.90% |
| 31 Mar, 16 | 17,711,959 | -3.59% |
| 31 Dec, 15 | 18,370,848 | -47.29% |
| 30 Sep, 15 | 34,854,573 | 16704.11% |
| 30 Jun, 15 | 207,417 | - |
Arbutus Biopharma (ABUS) has 42.71M shares outstanding as of 30 Jun 24, down -48.57% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 24.32% | 0.97% |
| 31 Mar, 24 | 50.04% | 2.27% |
| 31 Dec, 23 | 46.91% | 2.58% |
| 30 Sep, 23 | 42.63% | 2.54% |
| 30 Jun, 23 | 40.95% | 2.74% |
| 31 Mar, 23 | 38.63% | 3.00% |
| 31 Dec, 22 | 35.88% | 3.78% |
| 30 Sep, 22 | 30.82% | 3.48% |
| 30 Jun, 22 | 29.76% | 3.41% |
| 31 Mar, 22 | 29.55% | 1.93% |
| 31 Dec, 21 | 39.18% | 3.30% |
| 30 Sep, 21 | 34.44% | 3.87% |
| 30 Jun, 21 | 29.83% | 3.86% |
| 31 Mar, 21 | 27.79% | 3.23% |
| 31 Dec, 20 | 29.35% | 3.18% |
| 30 Sep, 20 | 30.37% | 2.16% |
| 30 Jun, 20 | 37.53% | 2.49% |
| 31 Mar, 20 | 38.83% | 3.02% |
| 31 Dec, 19 | 35.85% | 3.06% |
| 30 Sep, 19 | 34.24% | 2.48% |
| 30 Jun, 19 | 37.17% | 1.99% |
| 31 Mar, 19 | 43.25% | 2.26% |
| 31 Dec, 18 | 43.71% | 2.33% |
| 30 Sep, 18 | 43.33% | 2.68% |
| 30 Jun, 18 | 40.22% | 3.61% |
| 31 Mar, 18 | 33.37% | 0.86% |
| 31 Dec, 17 | 62.12% | 1.72% |
| 30 Sep, 17 | 60.16% | 1.32% |
| 30 Jun, 17 | 67.50% | 1.51% |
| 31 Mar, 17 | 66.88% | 1.51% |
| 31 Dec, 16 | 66.64% | 1.73% |
| 30 Sep, 16 | 62.13% | 5.61% |
| 30 Jun, 16 | 33.29% | 2.80% |
| 31 Mar, 16 | 34.46% | 2.11% |
| 31 Dec, 15 | 40.41% | 0.86% |
| 30 Sep, 15 | 68.67% | 48604.23% |
| 30 Jun, 15 | 0.38% | - |
As of 30 Jun 24, Arbutus Biopharma is held by 24.32% institutional shareholders, representing a 0.97% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 52 | -8.77% |
| 31 Mar, 24 | 57 | 9.62% |
| 31 Dec, 23 | 52 | 33.33% |
| 30 Sep, 23 | 39 | -20.41% |
| 30 Jun, 23 | 49 | -18.33% |
| 31 Mar, 23 | 60 | 5.26% |
| 31 Dec, 22 | 57 | -6.56% |
| 30 Sep, 22 | 61 | 15.09% |
| 30 Jun, 22 | 53 | - |
| 31 Mar, 22 | 53 | -33.75% |
| 31 Dec, 21 | 80 | 42.86% |
| 30 Sep, 21 | 56 | 27.27% |
| 30 Jun, 21 | 44 | 2.33% |
| 31 Mar, 21 | 43 | -14.00% |
| 31 Dec, 20 | 50 | 21.95% |
| 30 Sep, 20 | 41 | 46.43% |
| 30 Jun, 20 | 28 | 3.70% |
| 31 Mar, 20 | 27 | -3.57% |
| 31 Dec, 19 | 28 | 64.71% |
| 30 Sep, 19 | 17 | -48.48% |
| 30 Jun, 19 | 33 | 13.79% |
| 31 Mar, 19 | 29 | - |
| 31 Dec, 18 | 29 | -43.14% |
| 30 Sep, 18 | 51 | 10.87% |
| 30 Jun, 18 | 46 | 155.56% |
| 31 Mar, 18 | 18 | -47.06% |
| 31 Dec, 17 | 34 | 30.77% |
| 30 Sep, 17 | 26 | 18.18% |
| 30 Jun, 17 | 22 | 4.76% |
| 31 Mar, 17 | 21 | -41.67% |
| 31 Dec, 16 | 36 | 50.00% |
| 30 Sep, 16 | 24 | 4.35% |
| 30 Jun, 16 | 23 | - |
| 31 Mar, 16 | 23 | - |
| 31 Dec, 15 | 23 | -55.77% |
| 30 Sep, 15 | 52 | 5100.00% |
| 30 Jun, 15 | 1 | - |
52 institutional shareholders have increased their position in ABUS stock as of 30 Jun 24 compared to 57 in the previous quarter (a -8.77% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | -50.00% |
| 31 Mar, 24 | 32 | 14.29% |
| 31 Dec, 23 | 28 | 16.67% |
| 30 Sep, 23 | 24 | -22.58% |
| 30 Jun, 23 | 31 | - |
| 31 Mar, 23 | 31 | -3.13% |
| 31 Dec, 22 | 32 | -3.03% |
| 30 Sep, 22 | 33 | -10.81% |
| 30 Jun, 22 | 37 | - |
| 31 Mar, 22 | 37 | 76.19% |
| 31 Dec, 21 | 21 | -12.50% |
| 30 Sep, 21 | 24 | 14.29% |
| 30 Jun, 21 | 21 | -16.00% |
| 31 Mar, 21 | 25 | 78.57% |
| 31 Dec, 20 | 14 | -6.67% |
| 30 Sep, 20 | 15 | 50.00% |
| 30 Jun, 20 | 10 | -9.09% |
| 31 Mar, 20 | 11 | -35.29% |
| 31 Dec, 19 | 17 | -15.00% |
| 30 Sep, 19 | 20 | 11.11% |
| 30 Jun, 19 | 18 | -5.26% |
| 31 Mar, 19 | 19 | -17.39% |
| 31 Dec, 18 | 23 | -4.17% |
| 30 Sep, 18 | 24 | 100.00% |
| 30 Jun, 18 | 12 | -42.86% |
| 31 Mar, 18 | 21 | 90.91% |
| 31 Dec, 17 | 11 | -26.67% |
| 30 Sep, 17 | 15 | 15.38% |
| 30 Jun, 17 | 13 | -40.91% |
| 31 Mar, 17 | 22 | 83.33% |
| 31 Dec, 16 | 12 | -7.69% |
| 30 Sep, 16 | 13 | -13.33% |
| 30 Jun, 16 | 15 | -6.25% |
| 31 Mar, 16 | 16 | -11.11% |
| 31 Dec, 15 | 18 | - |
| 30 Sep, 15 | - | - |
| 30 Jun, 15 | - | - |
16 institutional shareholders have reduced their position in ABUS stock as of 30 Jun 24 compared to 32 in the previous quarter (a -50.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 93 | -27.34% | 42,710,818 | -48.57% | 24.32% | 0.97% | 52 | -8.77% | 16 | -50.00% |
| 31 Mar, 24 | 128 | 5.79% | 83,042,471 | 5.67% | 50.04% | 2.27% | 57 | 9.62% | 32 | 14.29% |
| 31 Dec, 23 | 121 | 15.24% | 78,585,833 | 11.02% | 46.91% | 2.58% | 52 | 33.33% | 28 | 16.67% |
| 30 Sep, 23 | 105 | -10.26% | 70,787,020 | 6.95% | 42.63% | 2.54% | 39 | -20.41% | 24 | -22.58% |
| 30 Jun, 23 | 117 | -10.00% | 66,185,386 | 6.00% | 40.95% | 2.74% | 49 | -18.33% | 31 | - |
| 31 Mar, 23 | 130 | 8.33% | 62,438,184 | 15.29% | 38.63% | 3.00% | 60 | 5.26% | 31 | -3.13% |
| 31 Dec, 22 | 120 | -9.77% | 54,155,892 | 16.36% | 35.88% | 3.78% | 57 | -6.56% | 32 | -3.03% |
| 30 Sep, 22 | 133 | 12.71% | 46,543,439 | 5.15% | 30.82% | 3.48% | 61 | 15.09% | 33 | -10.81% |
| 30 Jun, 22 | 118 | -5.60% | 44,265,785 | 0.91% | 29.76% | 3.41% | 53 | - | 37 | - |
| 31 Mar, 22 | 125 | -8.76% | 43,865,375 | 10.55% | 29.55% | 1.93% | 53 | -33.75% | 37 | 76.19% |
| 31 Dec, 21 | 137 | 18.10% | 39,680,290 | 13.74% | 39.18% | 3.30% | 80 | 42.86% | 21 | -12.50% |
| 30 Sep, 21 | 116 | 20.83% | 34,886,241 | 20.74% | 34.44% | 3.87% | 56 | 27.27% | 24 | 14.29% |
| 30 Jun, 21 | 96 | -4.95% | 28,892,880 | 11.28% | 29.83% | 3.86% | 44 | 2.33% | 21 | -16.00% |
| 31 Mar, 21 | 101 | 16.09% | 25,963,904 | 16.64% | 27.79% | 3.23% | 43 | -14.00% | 25 | 78.57% |
| 31 Dec, 20 | 87 | 17.57% | 22,260,347 | -7.80% | 29.35% | 3.18% | 50 | 21.95% | 14 | -6.67% |
| 30 Sep, 20 | 74 | 51.02% | 24,143,336 | -7.57% | 30.37% | 2.16% | 41 | 46.43% | 15 | 50.00% |
| 30 Jun, 20 | 49 | 4.26% | 26,122,035 | -0.62% | 37.53% | 2.49% | 28 | 3.70% | 10 | -9.09% |
| 31 Mar, 20 | 47 | -14.55% | 26,283,816 | 8.33% | 38.83% | 3.02% | 27 | -3.57% | 11 | -35.29% |
| 31 Dec, 19 | 55 | 25.00% | 24,262,246 | 24.65% | 35.85% | 3.06% | 28 | 64.71% | 17 | -15.00% |
| 30 Sep, 19 | 44 | -24.14% | 19,463,851 | -7.81% | 34.24% | 2.48% | 17 | -48.48% | 20 | 11.11% |
| 30 Jun, 19 | 58 | -18.31% | 21,113,654 | -12.43% | 37.17% | 1.99% | 33 | 13.79% | 18 | -5.26% |
| 31 Mar, 19 | 71 | -5.33% | 24,109,692 | -0.27% | 43.25% | 2.26% | 29 | - | 19 | -17.39% |
| 31 Dec, 18 | 75 | -18.48% | 24,175,304 | 0.67% | 43.71% | 2.33% | 29 | -43.14% | 23 | -4.17% |
| 30 Sep, 18 | 92 | 24.32% | 24,014,986 | 8.13% | 43.33% | 2.68% | 51 | 10.87% | 24 | 100.00% |
| 30 Jun, 18 | 74 | 42.31% | 22,208,597 | 20.85% | 40.22% | 3.61% | 46 | 155.56% | 12 | -42.86% |
| 31 Mar, 18 | 52 | 1.96% | 18,377,136 | -46.28% | 33.37% | 0.86% | 18 | -47.06% | 21 | 90.91% |
| 31 Dec, 17 | 51 | -3.77% | 34,210,466 | 3.62% | 62.12% | 1.72% | 34 | 30.77% | 11 | -26.67% |
| 30 Sep, 17 | 53 | 10.42% | 33,015,033 | -10.50% | 60.16% | 1.32% | 26 | 18.18% | 15 | 15.38% |
| 30 Jun, 17 | 48 | -12.73% | 36,888,158 | 1.56% | 67.50% | 1.51% | 22 | 4.76% | 13 | -40.91% |
| 31 Mar, 17 | 55 | -6.78% | 36,323,022 | 0.36% | 66.88% | 1.51% | 21 | -41.67% | 22 | 83.33% |
| 31 Dec, 16 | 59 | 11.32% | 36,191,006 | 8.56% | 66.64% | 1.73% | 36 | 50.00% | 12 | -7.69% |
| 30 Sep, 16 | 53 | -1.85% | 33,336,170 | 89.93% | 62.13% | 5.61% | 24 | 4.35% | 13 | -13.33% |
| 30 Jun, 16 | 54 | 1.89% | 17,551,752 | -0.90% | 33.29% | 2.80% | 23 | - | 15 | -6.25% |
| 31 Mar, 16 | 53 | - | 17,711,959 | -3.59% | 34.46% | 2.11% | 23 | - | 16 | -11.11% |
| 31 Dec, 15 | 53 | -5.36% | 18,370,848 | -47.29% | 40.41% | 0.86% | 23 | -55.77% | 18 | - |
| 30 Sep, 15 | 56 | 5500.00% | 34,854,573 | 16704.11% | 68.67% | 48604.23% | 52 | 5100.00% | - | - |
| 30 Jun, 15 | 1 | - | 207,417 | - | 0.38% | - | 1 | - | - | - |
Arbutus Biopharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Arbutus Biopharma's stock was made by MANCHESTER KEITH S on Aug 16 2024, selling 8,846 shares at $3.69 per share (valued at $32.64K).
Arbutus Biopharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 2 | 50.00% |
| Q2 2024 | 6 | - | - |
| Q1 2024 | 10 | 4 | 250.00% |
| Q3 2023 | 3 | 8 | 37.50% |
| Q2 2023 | 5 | - | - |
| Q1 2023 | 10 | - | - |
| Q2 2022 | 9 | - | - |
| Q1 2022 | 6 | - | - |
| Q4 2021 | 2 | 2 | 100.00% |
| Q2 2021 | 6 | - | - |
| Q1 2021 | 6 | 1 | 600.00% |
| Q4 2020 | - | 2 | - |
| Q3 2020 | 2 | 1 | 200.00% |
| Q2 2020 | 7 | - | - |
| Q1 2020 | 6 | - | - |
| Q3 2019 | 7 | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | 6 | - | - |
| Q4 2018 | 6 | 4 | 150.00% |
| Q3 2018 | - | 7 | - |
1 total buy trades, and 2 total sell trades (buy/sell ratio of 0.50%) were made by Arbutus Biopharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | 4 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 1 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 1 | - |
| Q4 2020 | - | 2 | - |
| Q3 2020 | - | 1 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | - | 7 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Arbutus Biopharma's stocks.
ABUS Ownership FAQ
Who Owns Arbutus Biopharma?
Arbutus Biopharma is owned by institutional shareholders (24.32%), insiders (22.30%), and public (53.38%). The largest institutional shareholder of Arbutus Biopharma is MORGAN STANLEY (11.93% of total shares) and the top mutual fund owner is Jacob Funds Inc. (0.75% of total shares).
Who are the major institutional shareholders of Arbutus Biopharma?
Arbutus Biopharma's major institutional shareholders are MORGAN STANLEY, WHITEFORT CAPITAL MANAGEMENT, LP, BLACKROCK INC., TWO SEAS CAPITAL LP, and VANGUARD GROUP INC. The top five shareholders own together 34.72% of the company's share outstanding.
How many Arbutus Biopharma shareholders are there?
As of Jun 2024, there are 93 institutional shareholders of Arbutus Biopharma.
What percentage of Arbutus Biopharma is owned by MORGAN STANLEY?
MORGAN STANLEY owns 20.96M shares of Arbutus Biopharma, representing 11.93% of the company's total shares outstanding, valued at $64.77M (as of Jun 2024).
What percentage of Arbutus Biopharma is owned by WHITEFORT CAPITAL MANAGEMENT, LP?
As of Jun 2024, WHITEFORT CAPITAL MANAGEMENT, LP holds 12.87M shares of Arbutus Biopharma (ABUS), compromising 7.33% of the company, valued at $39.76M.
What percentage of Arbutus Biopharma is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Arbutus Biopharma. The company owns 11.55M of the company's shares outstanding (worth $35.7M).